BWX Technologies, Inc. · BWXT · FY2026 Q2 · Calendar Q3 2026

BWXT raises 2026 outlook as commercial nuclear demand accelerates

The quarter supports a constructive demand-and-growth case: management described strong commercial nuclear activity, higher backlog and a raised outlook. Whether that growth converts into durable returns depends on orders, capacity execution, financing and regulatory progress.

Reported After market closeNYSEIndustrials $11.95B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $1.07 Consensus $1.04
EPS surprise +2.9% Reported versus consensus
Reported revenue $901.6M Consensus $902.4M
Revenue surprise -0.1% Reported versus consensus

Market reaction

event-close to next-session close
Stock move -0.8% Event window
SPY move +1.8% Same window
Abnormal move -2.6% Stock minus SPY
Volume 1.9× Versus trailing sessions
Subsequent drift -6.3% Up to 20 sessions
BWXTSPY benchmark

Ask FN2 about BWXT FY2026 Q2

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

BWXT reported Q2 FY2026 revenue growth of 18% year over year, while commercial operations revenue rose 72% and adjusted EBITDA more than doubled. Backlog was $8.4 billion, up 40% year over year, with book-to-bill of 1.7x. Management raised its full-year revenue, EBITDA and free-cash-flow outlook. The company also described the medical-business sale and ongoing investment in U.S. manufacturing capacity.

Guidance delta

Management raised full-year guidance to approximately $3.8 billion in revenue, $662–$672 million in EBITDA and $345–$360 million in free cash flow. The supplied analysis does not provide the prior ranges needed to quantify the change.

Key takeaways

  • Commercial operations were the clearest growth area, with revenue up 72% and adjusted EBITDA more than doubling, according to the supplied call analysis.
  • Backlog reached $8.4 billion, up 40% year over year, and book-to-bill was 1.7x.
  • Management raised full-year revenue, EBITDA and free-cash-flow guidance.
  • Capacity expansion and potential reactor-related opportunities are strategic priorities, but conversion into results depends on execution and awards.

Management priorities

  • Expand U.S. commercial manufacturing capacity, including work on an East Coast site and the DOE grant-supported expansion.
  • Advance the centrifuge and HPDU programs and continue development of mPower licensing and floating-nuclear feasibility work.
  • Pursue new nuclear-equipment orders across SMR, AP1000 and large-reactor opportunities.

Follow BWXT with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
BWXT EPS earnings history estimate and actual scatter chart 10 reported fiscal quarters and 2 future estimate-only quarters. Q2 '24 estimate $0.75 Q2 '24 actual $0.82, beat Q3 '24 estimate $0.78 Q3 '24 actual $0.83, beat Q2 '25 estimate $0.79 Q2 '25 actual $1.02, beat Q3 '25 estimate $0.85 Q3 '25 actual $1.00, beat Q4 '25 estimate $0.89 Q4 '25 actual $1.08, beat Q1 '26 estimate $0.92 Q1 '26 actual $1.12, beat Q2 '26 estimate $1.04 Q2 '26 actual $1.07, beat Q3 '26 estimate $1.18 Q3 '26 actual $1.26, beat Q4 '26 estimate $1.33 Q1 '27 estimate $1.18
Show 2 more >

Analyst Consensus ?

ConsensusBuy20 ratings
Bullish1470.0%
Neutral525.0%
Bearish15.0%

Analyst 52W Price Targets

$130.47Previous close
$70Low
$191.54Average
$255High

Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Nov 3, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
JP Morgan Overweight OverweightMaintainOct 13, 2026
Truist Securities Hold HoldMaintainOct 6, 2026
Northland Capital Markets Outperform OutperformMaintainSep 30, 2026
Guggenheim Buy BuyMaintainSep 30, 2026
BTIG Buy BuyMaintainSep 30, 2026
B of A Securities Buy BuyMaintainSep 30, 2026
BNP Paribas Neutral NeutralMaintainSep 24, 2026
Wells Fargo Equal Weight UnderweightUpgradeAug 27, 2026
Seaport Global Buy NeutralUpgradeJun 18, 2026
Deutsche Bank Buy HoldUpgradeMay 15, 2026
Maxim Group Hold BuyDowngradeAug 6, 2025
CLSA Outperform OutperformMaintainMay 27, 2025
Barclays Underweight UnderweightMaintainDec 16, 2024
Alembic Global Overweight NeutralUpgradeNov 12, 2024
Baird Outperform NeutralUpgradeAug 4, 2023
Credit Suisse Outperform OutperformMaintainMay 9, 2023
SunTrust Robinson Humphrey Buy HoldUpgradeMar 11, 2020
Bank of America Neutral BuyDowngradeMay 24, 2018
Drexel Hamilton Buy HoldUpgradeNov 9, 2016
Sidoti & Co. Buy BuyMaintainMar 18, 2016
Show less

Named analyst price targets

Upside is calculated against the persisted previous close $130.47. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Truist FinancialAnalyst unavailable$182$135.35 +39.5%Oct 6, 2026
OppenheimerAnalyst unavailable$210$137 +61.0%Oct 1, 2026
Northland SecuritiesJeff Grampp$220$136.62 +68.6%Sep 30, 2026
GuggenheimAnalyst unavailable$192$148.53 +47.2%Sep 14, 2026
JefferiesLaurence Alexander$181$155.67 +38.7%Sep 3, 2026
Wells FargoDavid Strauss$170$153.16 +30.3%Aug 27, 2026
Truist FinancialAnalyst unavailable$202$172.43 +54.8%Aug 14, 2026
Seaport GlobalAnalyst unavailable$245$205.4 +87.8%Jun 22, 2026
Deutsche BankScott Deuschle$255$210.94 +95.4%May 15, 2026
Deutsche BankAnalyst unavailable$205$213.52 +57.1%May 5, 2026
BNP ParibasAnalyst unavailable$215$204.08 +64.8%Jan 15, 2026
Truist FinancialMichael Ciarmoli$205$193.2 +57.1%Jan 9, 2026
Seaport GlobalAnalyst unavailable$195$175.28 +49.5%Nov 21, 2025
Truist FinancialAnalyst unavailable$200$204.51 +53.3%Nov 4, 2025
Northland SecuritiesJeff Grampp$225$204.56 +72.5%Nov 4, 2025
Truist FinancialMichael Ciarmoli$173$205.56 +32.6%Oct 15, 2025
Deutsche BankAnalyst unavailable$180$191.39 +38.0%Oct 8, 2025
Northland SecuritiesJeff Grampp$205$166.13 +57.1%Sep 10, 2025
Truist FinancialMichael Ciarmoli$145$182 +11.1%Aug 5, 2025
Seaport GlobalAnalyst unavailable$145$100.49 +11.1%Apr 1, 2025
Maxim GroupTate Sullivan$140$114.69 +7.3%Jan 10, 2025
Deutsche BankScott Deuschle$129$113.28 -1.1%Oct 3, 2024
Deutsche BankScott Deuschle$107$88.95 -18.0%Jun 10, 2024
Deutsche BankScott Deuschle$110$98.88 -15.7%May 7, 2024
Truist FinancialMichael Ciarmoli$95$101.47 -27.2%Mar 25, 2024
Truist FinancialMichael Ciarmoli$83$74 -36.4%Aug 14, 2023
Maxim GroupAnalyst unavailable$70$60.26 -46.3%Nov 29, 2022
Show less

Track every rating change on BWXT the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

BWX Technologies, Inc. operates globally, specializing in the production and sale of nuclear components across the United States, Canada, and other international regions. The company's multifaceted operations are categorized into three distinct segments: Nuclear Operations Group, Nuclear Power Group, and Nuclear Services Group. The Nuclear Operations Group is a pivotal supplier of precision naval and critical nuclear components, including reactors, nuclear fuel, and assemblies, primarily supporting the United States Department of Energy/National Nuclear Security Administration's Naval Nuclear Propulsion Program. This segment also fabricates missile launch tubes for U.S. Navy submarines, produces specialized close-tolerance equipment for various nuclear applications, and is involved in converting Cold War-era stockpiles of high-enriched uranium.…

Historical context

All BWXT earnings

Industrials peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the BWXT recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-08-04T15:11:59.527199+00:00
  2. FN2 earnings calendar · 2026-09-08T01:23:13.784197+00:00
  3. Polygon adjusted daily market bars · 2026-11-03T08:50:50.292291+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-03T08:50:50.289514+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-11-03. For educational purposes only; not investment advice.